BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28088540)

  • 1. Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes.
    Li L; Zheng G; Chen J; Ge M; Jiang W; Lu Y
    Metab Eng; 2017 Mar; 40():80-92. PubMed ID: 28088540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic engineering of Streptomyces coelicolor for enhanced prodigiosins (RED) production.
    Liu P; Zhu H; Zheng G; Jiang W; Lu Y
    Sci China Life Sci; 2017 Sep; 60(9):948-957. PubMed ID: 28785950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. aMSGE: advanced multiplex site-specific genome engineering with orthogonal modular recombinases in actinomycetes.
    Li L; Wei K; Liu X; Wu Y; Zheng G; Chen S; Jiang W; Lu Y
    Metab Eng; 2019 Mar; 52():153-167. PubMed ID: 30529239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes.
    Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):343-70. PubMed ID: 26364200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering Salinispora tropica for heterologous expression of natural product biosynthetic gene clusters.
    Zhang JJ; Moore BS; Tang X
    Appl Microbiol Biotechnol; 2018 Oct; 102(19):8437-8446. PubMed ID: 30105571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites.
    Komatsu M; Komatsu K; Koiwai H; Yamada Y; Kozone I; Izumikawa M; Hashimoto J; Takagi M; Omura S; Shin-ya K; Cane DE; Ikeda H
    ACS Synth Biol; 2013 Jul; 2(7):384-96. PubMed ID: 23654282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iteratively improving natamycin production in Streptomyces gilvosporeus by a large operon-reporter based strategy.
    Wang Y; Tao Z; Zheng H; Zhang F; Long Q; Deng Z; Tao M
    Metab Eng; 2016 Nov; 38():418-426. PubMed ID: 27746324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria.
    Belknap KC; Park CJ; Barth BM; Andam CP
    Sci Rep; 2020 Feb; 10(1):2003. PubMed ID: 32029878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Sequencing of
    Zhang C; Ding W; Qin X; Ju J
    Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31635159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Biology Tools for Novel Secondary Metabolite Discovery in
    Lee N; Hwang S; Lee Y; Cho S; Palsson B; Cho BK
    J Microbiol Biotechnol; 2019 May; 29(5):667-686. PubMed ID: 31091862
    [No Abstract]   [Full Text] [Related]  

  • 11. Engineering of Streptomyces lividans for heterologous expression of secondary metabolite gene clusters.
    Ahmed Y; Rebets Y; Estévez MR; Zapp J; Myronovskyi M; Luzhetskyy A
    Microb Cell Fact; 2020 Jan; 19(1):5. PubMed ID: 31918711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and activation of novel biosynthetic gene clusters by genome mining in the kirromycin producer Streptomyces collinus Tü 365.
    Iftime D; Kulik A; Härtner T; Rohrer S; Niedermeyer TH; Stegmann E; Weber T; Wohlleben W
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):277-91. PubMed ID: 26433383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterologous expression of natural product biosynthetic gene clusters in Streptomyces coelicolor: from genome mining to manipulation of biosynthetic pathways.
    Gomez-Escribano JP; Bibb MJ
    J Ind Microbiol Biotechnol; 2014 Feb; 41(2):425-31. PubMed ID: 24096958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of silent biosynthetic pathways and discovery of novel secondary metabolites in actinomycetes by co-culture with mycolic acid-containing bacteria.
    Hoshino S; Onaka H; Abe I
    J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):363-374. PubMed ID: 30488365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Single Biosynthetic Gene Cluster Is Responsible for the Production of Bagremycin Antibiotics and Ferroverdin Iron Chelators.
    Martinet L; Naômé A; Deflandre B; Maciejewska M; Tellatin D; Tenconi E; Smargiasso N; de Pauw E; van Wezel GP; Rigali S
    mBio; 2019 Aug; 10(4):. PubMed ID: 31409675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manipulation of metabolic pathways controlled by signaling molecules, inducers of antibiotic production, for genome mining in Streptomyces spp.
    Arakawa K
    Antonie Van Leeuwenhoek; 2018 May; 111(5):743-751. PubMed ID: 29476430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stepwise increase in pristinamycin II biosynthesis by Streptomyces pristinaespiralis through combinatorial metabolic engineering.
    Li L; Zhao Y; Ruan L; Yang S; Ge M; Jiang W; Lu Y
    Metab Eng; 2015 May; 29():12-25. PubMed ID: 25708513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Draft genome and secondary metabolite biosynthetic gene clusters of Streptomyces sp. strain 196.
    Kumar P; Chauhan A; Kumar M; Kuanr BK; Solanki R; Kapur MK
    Mol Biol Rep; 2020 Sep; 47(9):6741-6747. PubMed ID: 32888130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic engineering of antibiotic factories: new tools for antibiotic production in actinomycetes.
    Weber T; Charusanti P; Musiol-Kroll EM; Jiang X; Tong Y; Kim HU; Lee SY
    Trends Biotechnol; 2015 Jan; 33(1):15-26. PubMed ID: 25497361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond the Biosynthetic Gene Cluster Paradigm: Genome-Wide Coexpression Networks Connect Clustered and Unclustered Transcription Factors to Secondary Metabolic Pathways.
    Kwon MJ; Steiniger C; Cairns TC; Wisecaver JH; Lind AL; Pohl C; Regner C; Rokas A; Meyer V
    Microbiol Spectr; 2021 Oct; 9(2):e0089821. PubMed ID: 34523946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.